Top Biotech Stocks To Own For 2018

Generally speaking, companies that reside within the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But consider that with the risk of failure, which could spell disaster for a stock, comes great reward as well. Some companies can see a massive upside just from winning a single midstage trial or even achieving as much as a Fast Track designation from the U.S. Food and Drug Administration (FDA).

Basically, these updates within the industry have the potential to make or break these companies.

Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February. We have added some color, a recent trading history and a consensus analyst price target.

Its worth mentioning that these dates may be subject to change due to various internal and outside factors. Some of these changes are positive developments, and some can be disasters if a company is deeply financed.

Top Biotech Stocks To Own For 2018: Fresh Del Monte Produce, Inc.(FDP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Fresh Del Monte Produce (NYSE: FDP) and Limoneira (NASDAQ:LMNR) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Top Biotech Stocks To Own For 2018: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Flowers Foods, Inc. (NYSE: FLO) is estimated to post quarterly earnings at $0.31 per share on revenue of $1.20 billion.

    NetEase, Inc. (NASDAQ: NTES) is expected to post quarterly earnings at $2.19 per share on revenue of $2.18 billion.

  • [By Stephan Byrd]

    Flowers Foods (NYSE:FLO) posted its quarterly earnings results on Tuesday. The company reported $0.30 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.31 by ($0.01), Bloomberg Earnings reports. Flowers Foods had a net margin of 3.83% and a return on equity of 15.17%. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same period in the prior year, the company posted $0.25 earnings per share. The business’s revenue was up 1.5% on a year-over-year basis.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Flowers Foods (FLO)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Garrett Baldwin]

    Yesterday, North Korean officials threatened to pull out of next month’s summit with President Donald Trump over demands tied to its nuclear weapons program. The announcement comes when tensions are already high over increasing inflation fears, Japan’s economic contraction, and uncertainty around trade between the U.S. and China. Markets are likely to continue to react with uncertainty as the global political climate continues to grow increasingly volatile. WTI crude oil remained near $71.00 despite concerns as markets look to the Energy Information Administration on the state of U.S. inventory levels. Oil prices have been under pressure after the U.S. announced it would pull out of the Iran Nuclear Deal. The American Petroleum Institute projected Tuesday that U.S. stocks increased by 4.9 million barrels to 435 million barrels. The EIA will release its official report later this morning.
    Three Stocks to Watch Today: M, SBUX, AMZN
    Macy’s Inc. (NYSE: M) will lead another busy day of earnings reports. The retail company’s stock surged more than 12% this morning after a huge earnings report that crushed Wall Street expectations. The firm reported EPS of $0.48, topping expectations of $0.37 by 11 cents. The company also beat revenue expectations by roughly $100 million and experienced a huge jump in same-store sales. It doesn’t look like the U.S-China trade dispute will impact Starbucks Corporation (Nasdaq: SBUX). The coffee giant announced plans to build 3,000 new stores in China in the coming years. The company aims to double its store-front presence by the end of 2022 and hopes to double its profits and triple its revenue in the nation in the process. (Nasdaq: AMZN) is back in the news as it continues its slash-and-burn campaign against rival grocery store operators. This morning, the company announced it was slashing Whole Foods prices for its Prime members. The new price list includes 10% discounts on hundreds of items. The perks are rolling ou

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Macy's, Inc. (NYSE: M) to report quarterly earnings at $0.35 per share on revenue of $5.39 billion before the opening bell. Macy's shares fell 0.47 percent to $29.79 in after-hours trading.
    Analysts are expecting Cisco Systems, Inc. (NASDAQ: CSCO) to have earned $0.65 per share on revenue of $12.43 billion in the latest quarter. Cisco will release earnings after the markets close. Cisco shares declined 0.07 percent to $45.45 in after-hours trading.
    Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Boot Barn shares climbed 9.97 percent to $24.15 in the after-hours trading session.
    After the markets close, Flowers Foods, Inc. (NYSE: FLO) is projected to post quarterly earnings at $0.31 per share on revenue of $1.20 billion. Flowers Foods shares dropped 0.37 percent to $21.70 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Biotech Stocks To Own For 2018: CVR Energy Inc.(CVI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CVR Energy Inc. (NYSE:CVI) shares hit a new 52-week high and low during mid-day trading on Monday . The stock traded as low as $39.74 and last traded at $39.69, with a volume of 566335 shares traded. The stock had previously closed at $36.81.

  • [By Stephan Byrd]

    CVR Energy Inc. (NYSE:CVI) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $41.88 and last traded at $41.81, with a volume of 8024 shares trading hands. The stock had previously closed at $41.64.